Luyan Pharma Co

Luyan Pharma Co EBITDA

The EBITDA (Earnings Before Interest, Taxes, Depreciation & Amortization) of Luyan Pharma Co (002788.SZ) as of Oct 30, 2026 is 597.30 M CNY. In the previous year, EBITDA (Earnings Before Interest, Taxes, Depreciation & Amortization) was 590.44 M CNY — a change of 1.16% (higher).

EBITDA

597.30 MCNY

YoY

1.16%

Last updated:

EBITDA (Earnings Before Interest, Taxes, Depreciation & Amortization) of Luyan Pharma Co is 2025 597.30 M CNY. EBITDA (Earnings Before Interest, Taxes, Depreciation & Amortization) of Luyan Pharma Co was 2024 590.44 M CNY. It decreases by 1.16% higher compared to the previous year.

The Luyan Pharma Co EBITDA history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

EBITDA
Date
EBITDA
Jan 1, 2018
304.94 M CNY
Jan 1, 2019
397.13 M CNY
Jan 1, 2020
429.77 M CNY
Jan 1, 2021
527.34 M CNY
Jan 1, 2022
586.46 M CNY
Jan 1, 2023
594.84 M CNY
Jan 1, 2024
590.44 M CNY
Jan 1, 2025
597.30 M CNY
The Luyan Pharma Co EBITDA history
YEAREBITDAYoY
597.30 MCNY+1.16%
590.44 MCNY-0.74%
594.84 MCNY+1.43%
586.46 MCNY+11.21%
527.34 MCNY+22.70%
429.77 MCNY+8.22%
397.13 MCNY+30.23%
304.94 MCNY+33.36%
228.66 MCNY+32.08%
173.12 MCNY+1.11%
171.23 MCNY+4.93%
163.18 MCNY—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Get Free API Key

Luyan Pharma Co Stock analysis

What does Luyan Pharma Co do? Luyan Pharma Co Ltd, headquartered in Xiamen, Fujian, operates in the Health Care sector, specializing in the wholesale, distribution, manufacturing, and retail of pharmaceuticals, medical equipment, and healthcare products. The company, listed on 18 February 2016, serves medical institutions across Fujian Province, employing 5,286 full-time staff to support its operations in the region. Luyan Pharma Co is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Luyan Pharma Co stock

EBITDA (Earnings Before Interest, Taxes, Depreciation & Amortization) of Luyan Pharma Co is 597.30 M CNY in 2025.

EBITDA (Earnings Before Interest, Taxes, Depreciation & Amortization) of Luyan Pharma Co changed from 590.44 M CNY to 597.30 M CNY, representing a 1.16% change. The value is higher than the previous year.

On Eulerpool you can find the complete historical development of EBITDA (Earnings Before Interest, Taxes, Depreciation & Amortization) Luyan Pharma Co since 2006 – with annual values, charts, and detailed analysis.

EBITDA measures operating performance before the impact of financial structure, tax environment, and non-cash depreciation charges.

EBITDA = EBIT + Depreciation & Amortization

EBITDA (Earnings Before Interest, Taxes, Depreciation & Amortization)'s CNY is a key factor for investors. Changes in this metric can signal improving or deteriorating fundamentals, directly impacting the stock price. On Eulerpool, you can track EBITDA (Earnings Before Interest, Taxes, Depreciation & Amortization)'s Luyan Pharma Co historically and in real time.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Get Free API Key

Income Statement — Luyan Pharma Co

RevenueGross ProfitEBITEBITDANet IncomeEPSCost of Goods SoldR&D ExpensesSG&A ExpensesOperating ExpensesInterest ExpensePretax IncomeTax ExpenseDepreciation & AmortizationRevenue per ShareEBIT per ShareDiluted EPSEBITDA per ShareOther Income/Expense

All Key Metrics — Luyan Pharma Co